Director/PDMR Shareholding

CVS Group plc

07 January 2025

 

7 January 2025

CVS Group plc

("CVS" or the "Company")

PDMR Dealing

CVS, one of the UK's leading providers of integrated veterinary services, announces that it was made aware on 6 January 2025 that, as part of a dividend reinvestment plan, Joanne Shaw, Non-executive Director, purchased 14 ordinary shares of £0.002 each ("Ordinary Shares") at a price of 840.25 pence per Ordinary Share on 29 November 2024. Following this transaction, she holds a total of 1,562 Ordinary Shares, representing approximately 0.002% of the current Issued Share Capital of the Company.

The notification below, made in accordance with the requirements of the UK Market Abuse Regulation, provides further detail.

Contacts:

CVS Group plc                                                                                                                                via Camarco

Richard Fairman, CEO

Scott Morrison, Company Secretary

Peel Hunt LLP (Nominated Adviser & Broker)                                                                    [phone]

Christopher Golden / James Steel / Andrew Clark / Lalit Bose

   Berenberg (Joint Broker)                                                                                                        [phone]

Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser

Camarco (Financial PR)                                                                                             

Geoffrey Pelham-Lane                                                                                                              [phone]

Ginny Pulbrook                                                                                                                         [phone]

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Joanne Shaw
2	Reason for the notification
a)	Position/status	PDMR (Non-Executive Director)
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	CVS Group plc
b)	LEI	213800J41XDQ2NX48O05
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 0.2 pence each GB00B2863827
b)	Nature of the transaction	On-market purchase
c)	Price(s) and volume(s)	Price(s) - pence Volume(s) 840.25 14
d)	Aggregated information - Aggregated volume - Price	N/A - single transaction
e)	Date of the transaction	29 November 2024
f)	Place of the transaction	London Stock Exchange - AIM (XLON)

 

END